Skip to main content
. 2018 Jan 17;17(4):486–491. doi: 10.1080/15384101.2017.1417706

Table 1.

Data sources for the cell line and patient datasets.

Case samples Normal samples for tissue-based normalization Cell type Drug Experimental platform # of samples
GSE68950 [6] GSE14805 [19], GSE21212 [20] Cancer-RxGene cell lines Imatinib Sorafenib Affymetrix HT Human Genome U133A mRNA array 227
Current study GSE49972 [16] Renal carcinoma Sorafenib Illumina HumanHT-12v4 Expression BeadChip and CustomArray ECD 4 × 2K/12K 28 (13 responders, 15 non-respondres)
GSE31428 [3] GSE43458 [17] Lung adeno-carcinoma Sorafenib Affymetrix Human Gene 1.0 ST Array 37 (23 responders, 14 non-responders)
GSE2535 [4] GSE2191 [18] Chronic myeloid leukemia Imatinib Affymetrix Human Genome U95 Version 2 Array 28 (16 responders, 12 non-responders)